Aberrant hyperediting of the myeloma transcriptome by ADAR1 confers oncogenicity and is a marker of poor prognosis

Teoh, P. J., An, O., Chung, T.-H., Chooi, J. Y., Toh, S. H. M., Fan, S., Wang, W., Koh, B. T. H., Fullwood, M. J., Ooi, M. G., de Mel, S., Soekojo, C. Y., Chen, L., Ng, S. B., Yang, H., Chng, W. J.
American Society of Hematology (ASH)
Published 2018